Top Ten Equity Holdings and Exposures

Summary by AI BETAClose X

As of September 30, 2025, Polar Capital Global Healthcare Trust plc's top ten equity holdings comprised 41.8% of its portfolio, with Eli Lilly & Co leading at 7.1% and AstraZeneca at 6.1%. Sector exposure was primarily in Pharmaceuticals at 31.1%, followed by Healthcare Equipment at 24.2%, and Biotechnology at 21.1%. Geographically, the portfolio was heavily weighted towards the United States at 53.2%, with Denmark accounting for 13.7% and the United Kingdom at 6.1%. Cash holdings represented 1.9% of both sector and geographic exposure.

Disclaimer*

UK 100

Latest directors dealings